Clinical Trials Directory

Trials / Completed

CompletedNCT01539408

Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria

Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Gynuity Health Projects · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Women diagnosed with incomplete abortion in this health facility will be randomized to receive one of the following regimens: 400 mcg sublingual misoprostol in one dose or standard surgical treatment (MVA). The investigators hypothesize that treatment of incomplete abortion with misoprostol using 400 mcg administered sublingually will be as effective as surgical evacuation.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostolsingle dose of 400 mcg misoprostol administered sublingually
PROCEDUREsurgery Manual vacuum aspiration (MVA)standard surgical treatment

Timeline

Start date
2009-08-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2012-02-27
Last updated
2012-02-27

Locations

2 sites across 1 country: Nigeria

Source: ClinicalTrials.gov record NCT01539408. Inclusion in this directory is not an endorsement.